Pune, Maharashtra, India, February 11 2021 (Wiredrelease) Allied Analytics –:Animal vaccines are essential to ensure better animal health and welfare. Various vaccines such as attenuated vaccines, subunit vaccines, toxoid vaccines, and DNA vaccines help provide protection against multiple diseases, including rabies and foot & mouth disease. These vaccines offer cost-effective solutions instead of excessive antibiotic administration to treat such diseases.
“Animal Vaccines Market by Product Type and Animal Type: Global Opportunity Analysis and Industry Forecast, 2018 – 2025″,the global animal vaccines market accounted for $8,059 million in 2017, and is estimated to reach $12,845 million by 2025, registering a CAGR of 5.9% from 2018 to 2025.
Request Free Sample Report at: www.alliedmarketresearch.com/request-sample/1988
Animal vaccines are essential to ensure better animal health and welfare. Various vaccines such as attenuated vaccines, subunit vaccines, toxoid vaccines, and DNA vaccines aid to provide protection against multiple diseases, including rabies and foot & mouth disease. These vaccines offer cost-effective solutions to treat such diseases instead of excessive antibiotic administration.
Increase in adoption of companion animals in the developing countries is the major factor that drives the growth of this market. The market has witnessed moderate growth in recent years due to emerging diseases that affect livestock. The outbreak of epidemics results in severe mass wipeouts of animals, and is a growing concern for the industries dependent on products obtained through farm animals. Moreover, zoonotic diseases that affect animals pose a threat to the public health; hence avoiding transmission of such diseases via vaccination is a significant factor in disease management.
Cattle segment generated maximum revenue in 2019, accounting for over one-third share in the total revenue. This is attributed to increase in consumption of meat, milk, and dairy products, making sustainable animal health a vital aspect in disease management. However, the companion animal segment is anticipated to reach $12,845 million by 2025, registering a CAGR of 5.9%.
Attenuated vaccines segment dominated the product type segment with maximum share in 2015, in terms of revenue. Attenuated vaccines can provide stronger immunity as compared to other vaccines, which positively contributes toward the market growth.
In 2019, North America accounted for the highest revenue. Asia-Pacific is expected to show highest growth rate, registering a CAGR of 5.79%. Rise in disposable income, rise in animal healthcare expenditure, and growth in adoption of companion animals are the major factors that drive the growth of animal vaccines market in Asia-Pacific.
For Purchase Enquiry at: www.alliedmarketresearch.com/purchase-enquiry/1988
The report provides a comprehensive analysis of the key players operating in the global animal vaccines market. These players include Merck & Co., Inc., Zoetis Inc., Ceva Sant Animale, Sanofi S.A., Romvac, Vaxxinova, Biovac, Merial, and Anicon Labor GmbH.The other players operating in the global animal vaccines market include Nexvet, PHL Associates, Inc., Hygieia Biological Laboratories, Colorado Serum Company, Pfizer, and Arko Laboratories, Ltd.
Similar Reports with COVID-19 Impact:
Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.
This content has been published by Allied Analytics company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at [email protected].